DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/8x85dn/prenatal_and) has announced the addition of the "Global Prenatal and New-born Genetic Testing (PCR, FISH, aCGH, NIPT and MSS) Market: Forecasts to 2019" report to their offering.
Genetic testing is a systematic diagnostic and screening technique usually applied to detect risk of genetic disorders in unicellular and multicellular organisms. This technique in a broader sense includes biochemical tests for the detection of possible presence of genetic diseases or mutant forms of genes associated with increased risk of developing genetic disorders.
Genetic testing is broadly segmented as newborn screening, diagnostic testing, carrier testing, prenatal testing, pre-implantation testing, predictive and forensic testing. Prenatal and newborn genetic testing market is segmented on the basis of technology and geography. Prenatal and newborn genetic testing refers to the utilization of screening/diagnostic procedures of a fetus or a new born baby to detect chromosomal abnormalities such as Down syndrome, Patau syndrome and Edward syndrome.
The prenatal and newborn genetic testing market by technology is further segmented as diagnostic tests and screening tests. The diagnostic tests segment covers the global market for techniques such as polymerase chain reaction (PCR), fluorescence in-situ hybridization (FISH) and array comparative genomic hybridization (aCGH), while screening tests include non-invasive prenatal testing (NIPT) and maternal serum screening (MSS). The prenatal and newborn genetic testing market is driven by increasing maternal age and late pregnancies, technological advancements and growing awareness about genetic disorders in the fetus.
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Executive Summary
Chapter 3 Prenatal and Newborn Genetic Testing Market Overview
Chapter 4 Prenatal and Newborn Genetic Testing Market, by Technology
Chapter 5 Prenatal and Newborn Genetic Testing Market, by Geography
Chapter 6 Competitive Landscape
Chapter 7 Recommendations
Chapter 8 Company Profiles
Companies Mentioned:
- Agilent Technologies, Inc.
- Ariosa Diagnostics, Inc.
- Bio-Rad Laboratories, Inc.
- Illumina, Inc.
- Laboratory Corporation of America Holdings (LabCorp)
- Natera, Inc.
- PerkinElmer, Inc.
- Sequenom, Inc.
For more information visit http://www.researchandmarkets.com/research/8x85dn/prenatal_and
